BHCM
BHVN

Brevan Howard Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Brevan Howard Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,523
Closed -$326K – 1531
2024
Q3 		$326K Buy
+6,523
New +$326K ﹤0.01% 818

Other funds holding BHVN

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Brevan Howard Capital Management's BHVN Position: Q4 2024 in Review

Brevan Howard Capital Management sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2024, closing a stake of 6,523 shares — an estimated $326K sold.

Brevan Howard Capital Management first reported a position in BHVN in Q3 2024 and held it in 1 quarter. The position peaked at $326K in Q3 2024. 2 funds tracked by Wall St. Rank hold BHVN as of Q4 2024.

  • Brevan Howard Capital Management reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2024 after selling out during the quarter.
  • Brevan Howard Capital Management sold 6,523 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2024, an estimated $326K.
  • Brevan Howard Capital Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2024 and held it in 1 quarter.
  • Brevan Howard Capital Management's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $326K in Q3 2024.
  • 2 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2024.

Based on Brevan Howard Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.